Dmytro Kharkov

CME Group stock price forecast: rangebound momentum persists as CME consolidates above MA-200

CME Group stock price forecast: rangebound momentum persists as CME consolidates above MA-200
CME Group jumps 1.79% today

CME Group plans to launch Sui futures to provide more regulated access, with a targeted date of May 4. The company shared this update on its social media platform.

Highlights

  • CME is experiencing short- and medium-term bearish pressure, trading below key short-term moving averages but above longer-term support.
  • Recent technical momentum signals are mixed, with weak trend conviction and oversold readings countered by moderate buying interest and a modest price recovery.
  • CME is expected to trade sideways in the coming week within the 296.50–304.30 range, with key support at 280.83 and resistance near 305.99.

The launch remains subject to regulatory review. CME Group included a link to more information.

Short-term pressure and longer-term support as price tests key averages

CME is trading at $300.59, which is below the MA-20 ($303.02) and MA-50 ($305.99) but comfortably above the long-term MA-200 ($280.83), confirming short- and medium-term bearish pressure with longer-term support intact. The Ichimoku Kijun is at $306.74, placing immediate resistance overhead, while near-term support is found at MA-200 ($280.83) and key support lies at MA-100 ($290.43); near-term resistance is marked by MA-20 ($303.02) and key resistance at MA-50 ($305.99).

Mixed momentum and weak conviction as price recovers off weekly lows

Momentum signals on D1 are mixed, with the MACD indicating a bearish bias and ADX at a low level (15), suggesting weak directional conviction. RSI is leaning slightly bearish (47.46), while Stoch RSI indicates moderate buying interest and BBP flags oversold conditions with sellers dominating the session. CCI remains neutral. In today’s session, CME has risen sharply, gaining 1.79%. Over the past week, CME is trading at $300.59, up from a prev_week_close of $295.30, a gain of 1.79%. The price is currently in the lower part of the weekly range, with weekly volatility standing at 6.34%. Price action reflects a recovery from the weekly low, but remains well below the weekly high.

Sideways bias prevails as bullish odds rise above support band

For the coming 5–7 days, CME is expected to trade within a range of $296.50 to $304.30, in line with recent volatility and anchored above the 52-week low of $251.90 but below the 52-week high of $329.16. Probability analysis based on W1 signals (RSI, ADX, MACD, and MA-50) points to a very high probability (more than 80%) of a price increase, making a decline less likely. The baseline scenario is continued sideways movement within this corridor. A bullish scenario could unfold if CME breaks above near-term resistance at $303.02–$305.99, targeting higher levels, while a bearish scenario would see a dip below support at $290.43–$280.83, signaling vulnerability toward the lower end of its year-to-date range.

Previously it was reported that CME Group was experiencing short-term bearish momentum but was expected to stabilize near key technical levels. This article builds on that outlook by highlighting the prevailing scenario and suggests that traders closely monitor upcoming volatility for signals of a breakout or reversal from consolidation.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.